オハイオにおける食道腺癌の臨床試験
オハイオ内の拠点で、食道腺癌に関する12件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Miami Valley Hospital South, Centerville
- Miami Valley Hospital, Dayton
- Premier Blood and Cancer Center, Dayton
- 他3件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Strecker Cancer Center-Belpre, Belpre
- Miami Valley Hospital South, Centerville
- Adena Regional Medical Center, Chillicothe
- 他30件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05677490A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Local Institution - 0443, Cleveland
- Local Institution - 0222, Cleveland
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07221149Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati
- 他1件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07392892Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Taussig Cancer Center, Cleveland
被験者募集中健康なボランティア歓迎
50歳以上 · 全性別 · 2026/09/15更新 · NCT06687603Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
- Case Western Reserve University, Cleveland
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06732388Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- Cleveland VA Medical Research and Education Foundation, Cleveland
- University Hospitals Cleveland Medical Center Case Western University, Cleveland
- Cleveland Clinic Foundation, Cleveland
被験者募集中
18歳〜89歳 · 全性別 · 2026/09/11更新 · NCT05753748Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Columbus
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07431281A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- University of Cincinnati Cancer Center, Cincinnati
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/27更新 · NCT07544589A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Maumee
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07182149Obeticholic Acid for Prevention in Barrett's Esophagus
- Case Western Reserve University, Cleveland
- Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland
- University Hospitals Cleveland Medical Center, Cleveland
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT04939051First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Research Site, Cleveland
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07284186ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。